Bio-Techne (TECH) Capital Expenditures (2009 - 2026)
Bio-Techne's quarterly Capital Expenditures came in at $9.1 million in Q1 2026, down 10.24% year-on-year from $10.1 million in Q1 2025, and up 53.45% quarter-over-quarter from $5.9 million in Q4 2025.
Bio-Techne has reported Capital Expenditures for 18 years, with the latest figure at $9.1 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 10.24% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $25.3 million (down 42.72% YoY), and the FY2025 full-year result was $31.0 million, down 50.69% from the prior year.
- Capital Expenditures for Q1 2026 stood at $9.1 million, up from $5.9 million in the prior quarter.
- The five-year high for Capital Expenditures was $18.0 million in Q2 2024, with the low at $4.9 million in Q2 2025.
- Average Capital Expenditures over 5 years is $10.7 million, with a median of $10.1 million recorded in 2025.
- Year-over-year, Capital Expenditures surged 143.31% in 2023 and tumbled 72.8% in 2025.
- Tracing TECH's Capital Expenditures over 5 years: stood at $6.1 million in 2022, then soared by 143.31% to $14.9 million in 2023, then plunged by 54.11% to $6.8 million in 2024, then dropped by 13.19% to $5.9 million in 2025, then soared by 53.45% to $9.1 million in 2026.
- The last three Capital Expenditures figures came in at $9.1 million (Q1 2026), $5.9 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 9.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.09 Mn |
| Mar 31, 2026 | 9.09 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Dec 31, 2025 | 5.92 Mn |
| Sep 30, 2025 | 5.36 Mn |
| Sep 30, 2025 | 5.36 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | 10.12 Mn |
| Mar 31, 2025 | 10.12 Mn |
| Dec 31, 2024 | 6.82 Mn |
| Dec 31, 2024 | 6.82 Mn |
| Sep 30, 2024 | 9.17 Mn |
| Sep 30, 2024 | 9.17 Mn |
| Jun 30, 2024 | 17.98 Mn |
| Jun 30, 2024 | 17.98 Mn |
| Mar 31, 2024 | 16.44 Mn |
| Mar 31, 2024 | 16.44 Mn |
| Dec 31, 2023 | 14.86 Mn |
| Dec 31, 2023 | 14.86 Mn |
| Sep 30, 2023 | 13.59 Mn |
| Sep 30, 2023 | 13.59 Mn |
| Jun 30, 2023 | 10.83 Mn |
| Jun 30, 2023 | 10.83 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Mar 31, 2023 | 11.75 Mn |
| Dec 31, 2022 | 6.11 Mn |
| Dec 31, 2022 | 6.11 Mn |
| Sep 30, 2022 | 9.56 Mn |
| Sep 30, 2022 | 9.56 Mn |
| Jun 30, 2022 | 13.57 Mn |
| Jun 30, 2022 | 13.57 Mn |
| Mar 31, 2022 | 15.10 Mn |
| Mar 31, 2022 | 15.10 Mn |
| Dec 31, 2021 | 10.17 Mn |
| Dec 31, 2021 | 10.17 Mn |
| Sep 30, 2021 | 6.07 Mn |
| Sep 30, 2021 | 6.07 Mn |
| Jun 30, 2021 | 11.32 Mn |
| Jun 30, 2021 | 11.32 Mn |
| Mar 31, 2021 | 10.60 Mn |
| Mar 31, 2021 | 10.60 Mn |
| Dec 31, 2020 | 11.45 Mn |
| Dec 31, 2020 | 11.45 Mn |
| Sep 30, 2020 | 10.94 Mn |
| Sep 30, 2020 | 10.94 Mn |
| Jun 30, 2020 | 17.37 Mn |
| Jun 30, 2020 | 17.37 Mn |
| Mar 31, 2020 | 9.28 Mn |
| Mar 31, 2020 | 9.28 Mn |
| Dec 31, 2019 | 14.56 Mn |
| Dec 31, 2019 | 14.56 Mn |
| Sep 30, 2019 | 10.53 Mn |
| Sep 30, 2019 | 10.53 Mn |
| Jun 30, 2019 | 11.69 Mn |
| Jun 30, 2019 | 11.69 Mn |
| Mar 31, 2019 | 4.93 Mn |
| Mar 31, 2019 | 4.93 Mn |
| Dec 31, 2018 | 4.60 Mn |
| Dec 31, 2018 | 4.60 Mn |
| Sep 30, 2018 | 4.19 Mn |
| Sep 30, 2018 | 4.19 Mn |
| Jun 30, 2018 | 5.82 Mn |
| Jun 30, 2018 | 5.82 Mn |
| Mar 31, 2018 | 3.51 Mn |
| Mar 31, 2018 | 3.51 Mn |
| Dec 31, 2017 | 6.34 Mn |
| Dec 31, 2017 | 6.34 Mn |
| Sep 30, 2017 | 5.27 Mn |
| Sep 30, 2017 | 5.27 Mn |
| Jun 30, 2017 | 5.87 Mn |
| Jun 30, 2017 | 5.87 Mn |
| Mar 31, 2017 | 4.02 Mn |
| Mar 31, 2017 | 4.02 Mn |
| Dec 31, 2016 | 2.85 Mn |
| Dec 31, 2016 | 2.85 Mn |
| Sep 30, 2016 | 2.44 Mn |
| Sep 30, 2016 | 2.44 Mn |
| Jun 30, 2016 | 3.05 Mn |
| Jun 30, 2016 | 3.05 Mn |
| Mar 31, 2016 | 2.84 Mn |
| Mar 31, 2016 | 2.84 Mn |
| Dec 31, 2015 | 4.89 Mn |
| Dec 31, 2015 | 4.89 Mn |
| Sep 30, 2015 | 6.12 Mn |
| Sep 30, 2015 | 6.12 Mn |
| Jun 30, 2015 | 6.93 Mn |
| Jun 30, 2015 | 6.93 Mn |
| Mar 31, 2015 | 4.92 Mn |
| Mar 31, 2015 | 4.92 Mn |
| Dec 31, 2014 | 3.14 Mn |
| Dec 31, 2014 | 3.14 Mn |
| Sep 30, 2014 | 4.91 Mn |
| Sep 30, 2014 | 4.91 Mn |
| Jun 30, 2014 | 2.10 Mn |
| Jun 30, 2014 | 2.10 Mn |
| Mar 31, 2014 | 4.26 Mn |
| Mar 31, 2014 | 4.26 Mn |
| Dec 31, 2013 | 3.65 Mn |
| Dec 31, 2013 | 3.65 Mn |
| Sep 30, 2013 | 3.81 Mn |
| Sep 30, 2013 | 3.81 Mn |
| Jun 30, 2013 | 5.35 Mn |
| Jun 30, 2013 | 5.35 Mn |
| Mar 31, 2013 | 6.37 Mn |
| Mar 31, 2013 | 6.37 Mn |
| Dec 31, 2012 | 8.22 Mn |
| Dec 31, 2012 | 8.22 Mn |
| Sep 30, 2012 | 2.52 Mn |
| Sep 30, 2012 | 2.52 Mn |
| Jun 30, 2012 | 1.13 Mn |
| Jun 30, 2012 | 1.13 Mn |
| Mar 31, 2012 | 1.59 Mn |
| Mar 31, 2012 | 1.59 Mn |
| Dec 31, 2011 | 2.20 Mn |
| Dec 31, 2011 | 2.20 Mn |
| Sep 30, 2011 | 1.10 Mn |
| Sep 30, 2011 | 1.10 Mn |
| Jun 30, 2011 | 1.27 Mn |
| Jun 30, 2011 | 1.27 Mn |
| Mar 31, 2011 | 592,000.00 |
| Mar 31, 2011 | 592,000.00 |
| Dec 31, 2010 | 713,000.00 |
| Dec 31, 2010 | 713,000.00 |
| Sep 30, 2010 | 1.05 Mn |
| Sep 30, 2010 | 1.05 Mn |
| Jun 30, 2010 | 1.12 Mn |
| Jun 30, 2010 | 1.12 Mn |
| Mar 31, 2010 | 1.37 Mn |
| Mar 31, 2010 | 1.37 Mn |
| Dec 31, 2009 | 1.59 Mn |
| Dec 31, 2009 | 1.59 Mn |
| Sep 30, 2009 | 563,000.00 |
| Sep 30, 2009 | 563,000.00 |